Keywords: سرم آمیلوئید P; ACEi; Angiotensin converting enzyme inhibitors; ESRD; end stage renal disease; eGFR; estimated glomerular filtration rates; FLC; free light chain; PAS; periodic acid Schiff; RAAS; renin-angiotensin-aldosterone; SAP; serum amyloid P;
مقالات ISI سرم آمیلوئید P (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: سرم آمیلوئید P; Single-walled carbon nanotubes; Carbon nanotubes; Nanomaterials; Nanotoxicology; Pulmonary toxicology; Inflammation; Oxidative stress; Inhalation; Pharyngeal aspiration; Intratracheal instillation; ACE; angiotensin-converting enzyme; AD-SWCNTs; acetone/so
Shiga toxin 2a binds antithrombin and heparin, but does not directly activate platelets
Keywords: سرم آمیلوئید P; eHUS; Escherichia coli-induced hemolytic uremic syndrome; Stx; Shiga toxin; EHEC; Enterohemorrhagic Escherichia coli; AT; antithrombin; AKI; acute kidney injury; t-PA antigen; tissue plasminogen activator antigen; PAI-1; t-PA-plasminogen activator inhibit
IL-4 and serum amyloid P inversely regulate fibrocyte differentiation by targeting store-operated Ca2+ channels
Keywords: سرم آمیلوئید P; Fibrocytes; IL-4; Serum amyloid P; Differentiation; Store-operated Ca2+ channels;
Current insight in the localized insulin-derived amyloidosis (LIDA): clinico-pathological characteristics and differential diagnosis
Keywords: سرم آمیلوئید P; AA; amyloid A protein; AL; amyloid light-chain; CT; computerized tomography; H&E; hematoxylin and eosin; IHC; immunohistochemistry; LIDA; localized Insulin-derived amyloidosis; IICL; insulin-induced cutaneous lipohypertrophy; SAP; serum amyloid P; DM; dia
Case reportTransthyretin V122I amyloidosis with clinical and histological evidence of amyloid neuropathy and myopathy
Keywords: سرم آمیلوئید P; Hereditary amyloidosis; Transthyretin; Neuropathy; Myopathy; Cardiomyopathy; ATTR; Transthyretin amyloidosis; DPD; 99mTc-3,3-Diphosphono-1,2-Propanodicarboxylic acid; NAC; National Amyloidosis Centre; NYHA; New York Heart Association; SAP; Serum Amyloid P
Functional characterisation and expression analysis of recombinant serum amyloid P isoform 1 (RbSAP1) from rock bream (Oplegnathus fasciatus)
Keywords: سرم آمیلوئید P; Innate immunity; Oplegnathus fasciatus; Serum amyloid P; Pentraxin;
Recombinant human serum amyloid P in healthy volunteers and patients with pulmonary fibrosis
Keywords: سرم آمیلوئید P; Pulmonary fibrosis; Serum amyloid P; PRM-151; First-in-human clinical trial; Pentraxin-2; Macrophage; Fibrocyte; AE; adverse events; ELISA; enzyme linked immunoassay; ERS/ATS; European Respiratory Society/American Thoracic Society; FACS; fluorescence acti
Identification of new biomarkers for Down's syndrome in maternal plasma
Keywords: سرم آمیلوئید P; DS; Down's syndrome; SAMP; Serum Amyloid P; C1-inhibitor; Plasma C1-protease inhibitor; SELDI TOF MS; surface-enhanced laser desorption ionisation time of flight mass spectrometry; NSC; National Screening Committee; PLGS; ProteinLynx Global Server; ffDNA;
The development of a peptide SRM-based tandem mass spectrometry assay for prenatal screening of Down syndrome
Keywords: سرم آمیلوئید P; SRM, Multiple reaction monitoring; DS, Down syndrome; SAP, serum amyloid P; C1-inhibitor, plasma C1-protease inhibitor; PLGS, ProteinLynx Global Server; ffDNA, free foetal DNA; min, minutes; h, hoursDown syndrome; Serum amyloid P; Plasma C1-protease inhib
Proteinase 3 carries small unusual carbohydrates and associates with αlpha-defensins
Keywords: سرم آمیلوئید P; PR3; Proteinase 3; NHP; human neutrophil peptide; WG; Wegener's granulomatosis; PMN; polymorphonuclear leukocytes; PAR-2; protease-activated receptor-2; IFN-γ; interferon gamma; ANCA; anti-neutrophil cytoplasmic antibodies; MPO; myeloperoxidase; SAP; ser
TGF-beta driven lung fibrosis is macrophage dependent and blocked by Serum amyloid P
Keywords: سرم آمیلوئید P; Macrophage; TGFβ; Fibrosis; Monocyte; Serum amyloid P
Biomarkers of inflammation and amyloid-β phagocytosis in patients at risk of Alzheimer disease
Keywords: سرم آمیلوئید P; Alzheimer disease biomarkers; Amyloid-beta; Macrophage; Microglia; Astrocyte; Phagocytosis; Inflammation; Serum amyloid P; Complement; Neuron
Serum amyloid P attenuates M2 macrophage activation and protects against fungal spore-induced allergic airway disease
Keywords: سرم آمیلوئید P; Asthma; Aspergillus fumigatus; fungal-induced allergic airway disease; pentraxins; serum amyloid P component; macrophage; airway remodeling; BMDM; Bone marrow-derived macrophage; CRP; C-reactive protein; FcγR; Fcγ receptor; FITC; Fluorescein isothiocy